• Bio-Rad Picks Up GnuBIO, Droplet-Based Sequencing

    Bio-IT World News Brief | Bio-Rad has acquired GnuBIO, a next-generation droplet-based DNA sequencing technology. GnuBIO's DNA sequencing solution integrates the entire sample preparation workflow on a chip.

    Apr 11, 2014
  • Duke's Plans for the Soon-to-be Defunct Institute for Genome Sciences

    Duke Chronicle | Duke's plans for the Institute for Genome Sciences & Policy were made public in late March--a formal dismantling July 1.

    Apr 10, 2014
  • FDA Grants Breakthrough Status to Gene Therapy for First Time

    Bio-IT World News Brief | Celladon today became the first company to receive breakthrough status for a gene therapy treatment in development. The treatment, MYDICAR, is intended to reduce the risk of heart failure in patients with a deficiency of the enzyme SERCA2a.

    Apr 10, 2014
  • AWS, Google, Microsoft Chop Cloud Prices

    Computerworld | A string of price cuts from Google, Amazon Web Services, and Microsoft has further driven down the price of cloud computing.

    Apr 10, 2014
  • Aspera on Life with IBM, and Bio-IT World Expo Plans

    Bio-IT World | A few months after Aspera's acquisition by IBM, Bio-IT World caught up with Aspera CEO Michelle Munson, a Bio-IT World Conference & Expo speaker and exhibitor, to hear the latest on life at Big Blue and what’s new in Aspera’s pipeline. 

    Apr 10, 2014
  • India's Open Source Experiment Short on Funds, Talent

    Bio-IT World Roundup | More challenges for India's Open Source Drug Development project. The Indian Ministry of Science and Technology reportedly did not clear the cabinet note meant to extend funding for the Open Source Drug Discovery project and the project is facing a serious talent shortage.

    Apr 9, 2014
  • Mouse Models, Wayward Trials, and New Guidelines

    Bio-IT World Roundup | A March 26 Nature comment is getting press today. Steve Perrin, chief scientific officer at the ALS Therapy Development Institute in Cambridge, Mass., is frustrated with the mouse models driving ALS research.

    Apr 8, 2014
  • New Life for Cancer Immunotherapy

    Technology Review | Data presented at the American Association of Cancer Researchers (AACR) event over the weekend heralded the revival of cancer immunotherapy.

    Apr 7, 2014
  • Annual IT Worker Salary Survey Released

    Computerworld | Computerworld released its 2014 Salary Survey for tech workers today. Compared with last year, salaries inched up slowly, but with more employees seeing increases.

    Apr 7, 2014
  • 'Where Do I Get More Data?'

    Huffington Post | A practicing bioinformatician makes the case for genomic research organizations to make their data public.

    Apr 4, 2014
  • Schrödinger's New Platform for Real-Time Collaboration on Drug Design

    Bio-IT World | The new LiveDesign platform, released this week, allows computational and medicinal chemists to cooperate in the cloud, drawing new compounds and running predictive models on them during live sessions.

    Apr 4, 2014
  • Appistry Announces Commercial Version of GATK 3.0

    Bio-IT World News Brief | Appistry, which has managed the commercial releases of the Broad Institute's Genome Analysis Toolkit (GATK) since 2012, has released the GATK 3 for commercial use.

    Apr 3, 2014
  • Cornell Opens Center for Reproductive Genomics

    Cornell Chronicle | Cornell University has established a new Center for Reproductive Genomics (CRG) with the help of a five-year, $10 million grant from NIH.

    Apr 2, 2014
  • 23andMe Brings in New Regulatory Counsel

    Bio-IT World News Brief | This morning, 23andMe announced the appointment of industry veteran Kathy Hibbs as chief legal and regulatory officer, filling a role that has been vacant for nearly a year.

    Apr 2, 2014
  • Stem Cell Author Found Guilty of Scientific Misconduct

    Bio-IT World Roundup | A Japanese scientific committee yesterday found that the lead author of the acid-induced stem cell paper published in Nature is guilty of scientific misconduct.

    Apr 2, 2014
  • ACMG Changes Recommendations on Incidental Findings and Opting Out

    Bio-IT World | ACMG changes their recommendations on incidental findings in genomic testing, recommending that patients be given the option to opt out before testing occurs.

    Apr 1, 2014
  • Cloudera raises $900M, Intel Partnership

    ReadWrite | Cloudera just raised $900 million in its IPO, and is partnering with Intel. Intel dumped its own home-grown Hadoop distribution for Cloudera's version.

    Mar 31, 2014
  • Google Flu Trends Suffers from Inflammatory Response

    New York Times Blog | In the wake of a Science article criticizing the track record of Google Flu Trends, Steve Lohr speaks to both the article's authors and Google's engineers to understand what went wrong.

    Mar 28, 2014
  • March News and Product Briefs

    Bio-IT World | News and product releases from around the industry, including developments in gene therapy, mobile chemical modeling, and more.

    Mar 27, 2014
  • Toby Bloom on the New York Genome Center’s Crystallizing Clinical Vision

    Bio-IT World | With almost a year behind her, Toby Bloom, the New York Genome Center’s Deputy Science Director, Informatics, talks about the Center’s new projects, its clinical vision, and her dreams of a “be-all, end-all” multimodal database for genomic and clinical data.

    Mar 26, 2014